Dabur India Q4 and Full-Year FY25 Results:
Net profit declined 8% to ₹320 crores from ₹349.5 crores in Q4 FY24. Total income in Q4 FY25 remains unchanged at ₹2,971.3 crores from ₹2,943.5 crores in the same period last year. For the financial year 2025, the company reported a net profit of ₹1,767.6 crores and a total income of ₹13,113.2 crores, compared with ₹1,842.7 crores and ₹12,886.4 crores recorded last year, respectively.
About Dabur India Ltd
Dabur India Ltd is a leading FMCG company. It specializes in ayurvedic and natural healthcare products. It was founded in 1884. Dabur India has a rich legacy spanning over the centuries. The headquarters is located in New Delhi. Dabur's main products include healthcare items, hair care products, oral care items, home care products, food and beverages, and skin care and beauty products. The company falls under the Fast-Moving Consumer Goods (FMCG) sector. Dabur is India's largest Ayurvedic medicine manufacturer. Also, it is the world's largest natural and ayurvedic products maker. +
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-0.44%
Over 6 Months
-6.65%
Over 1 Year
-23.66%
Over 3 Years
-4.99%
Dabur India Ltd Summary
Close ₹472.95
Open ₹487.10
High ₹487.80
Low ₹471.45
Volume 37,27,720
Net Turnover (in Cr) ₹177.92
52Wk High ₹672
52Wk Low ₹433.30
52Wk High / Low
433.30
672
Dabur India Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹83,886.68
EPS (TTM) 7.91
Book Value (BV) 41.85
Div. Yield 1.69 %
P/E (TTM) 59.78
Price/Book Value 11.30
Delivery % 61.34 %
Face Value 1
Key Ratios
PE Ratio 61.40
PB Ratio 13.40
EV to Sales 10.22
PEG Ratio 6.18
ROA 19.46
ROE 22.86
Debt-Equity 0.11
Net Profit Margin 16.52
Operating Profit Margin 24.70
Dabur India Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 12,886.42 | 11,975.28 | 11,281.84 | 9,886.94 | 8,989.93 |
| Total Expenses | 10,527.17 | 9,754.97 | 8,926.36 | 7,829.91 | 7,162.28 |
| Profit Before Tax | 2,358.74 | 2,218.68 | 2,268.68 | 2,056.02 | 1,727.64 |
| Profit After Tax | 1,811.31 | 1,701.33 | 1,742.30 | 1,694.95 | 1,447.92 |
| Operating Profit After Depreciation | 2,483.43 | 2,298.55 | 2,394.08 | 2,087.84 | 1,877.19 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 3,792.69 | 3,535.61 | 2,258.83 | 2,192.42 | 2,201.13 |
| Total Non Current Assets | 9,443.06 | 9,405.41 | 7,967.99 | 6,071.46 | 4,473.75 |
| Total Current Assets | 5,679.62 | 4,248.96 | 4,316.54 | 4,775.67 | 4,880.26 |
| Total Assets | 15,122.68 | 13,654.37 | 12,284.53 | 10,847.13 | 9,354.01 |
| Total Shareholder's Fund | 9,866.30 | 8,973.26 | 8,381.30 | 7,663.53 | 6,605.75 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 2,013.47 | 1,488.43 | 1,802.33 | 2,114.67 | 1,613.62 |
| Net Cash Used In Investing Activities | -971.04 | -582.79 | -1,273.45 | -1,404.22 | -516.63 |
| Net Cash Used In Financing Activities | -1,161.18 | -1,035.24 | -490.49 | -613.41 | -1,042.97 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 9,553.22 | 9,076.52 | 8,521.05 | 7,461.38 | 6,586.70 |
| Total Expenses | 7,586.52 | 7,218.20 | 6,624.74 | 5,778.07 | 5,078.23 |
| Profit Before Tax | 1,966.70 | 1,828.67 | 1,896.31 | 1,683.31 | 1,408.47 |
| Profit After Tax | 1,509.21 | 1,373.26 | 1,432.93 | 1,381.89 | 1,170.35 |
| Operating Profit After Depreciation | 2,047.84 | 1,904.69 | 1,914.98 | 1,692.45 | 1,527.74 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 1,856.50 | 1,616.59 | 1,352.63 | 1,157.42 | 1,085.90 |
| Total Non Current Assets | 7,100.44 | 7,121.16 | 5,957.87 | 4,674.17 | 2,834.92 |
| Total Current Assets | 3,432.37 | 2,231.28 | 2,634.13 | 2,829.99 | 3,265.19 |
| Total Assets | 10,532.81 | 9,352.44 | 8,592 | 7,504.16 | 6,100.11 |
| Total Shareholder's Fund | 6,915.37 | 6,286.88 | 5,863.87 | 5,391.22 | 4,574.23 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 1,653.33 | 1,561.91 | 1,319.95 | 1,704.17 | 1,154.77 |
| Net Cash Used In Investing Activities | -736.09 | -617.20 | -681.70 | -1,120.37 | -330.28 |
| Net Cash Used In Financing Activities | -921.82 | -939.83 | -634.79 | -555.04 | -826 |
| Particulars (in ₹ Cr.) | 2025-03 | 2024-12 | 2024-09 | 2024-06 | 2024-03 |
|---|---|---|---|---|---|
| Total Revenue | 2,830.14 | 3,355.25 | 3,028.59 | 3,349.11 | 2,814.64 |
| Total Expenses | 2,403.27 | 2,673.36 | 2,476.04 | 2,694.28 | 2,348.23 |
| Profit Before Tax | 411.91 | 657.58 | 545.95 | 642.45 | 452.66 |
| Profit After Tax | 312.73 | 515.82 | 417.52 | 494.35 | 341.22 |
| Operating Profit after Depreciation | 568.03 | 810.42 | 704.31 | 784.23 | 595.26 |
| Particulars (in ₹ Cr.) | 2025-03 | 2024-12 | 2024-09 | 2024-06 | 2024-03 |
|---|---|---|---|---|---|
| Total Revenue | 1,964.71 | 2,448.26 | 2,143.58 | 2,514.16 | 2,039.46 |
| Total Expenses | 1,680.49 | 1,925.71 | 1,740.37 | 2,017.23 | 1,702.88 |
| Profit Before Tax | 316.71 | 535.75 | 428.92 | 526.96 | 373.12 |
| Profit After Tax | 250.54 | 418.08 | 329.21 | 405.39 | 283.15 |
| Operating Profit after Depreciation | 402.77 | 627.86 | 521.67 | 606.55 | 450.76 |
Dabur India Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 467
S2 461.05
S3 450.65
Pivot 477.40
R1 483.35
R2 493.75
R3 499.70
Moving Average
20 SMA 482.86
50 SMA 479.49
100 SMA 496.25
200 SMA 529.48
Dabur India Ltd Corporate Actions
Dabur India Ltd
₹2.75/Share
Announcement Date 08 Nov 2024
Record Date 08 Nov 2024
Div Yield 275%
Dabur India Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Hindustan Unilever Ltd | ₹2,334.35 | ₹5,48,476.84 |
| Nestle India Ltd | ₹2,387.20 | ₹2,30,163.60 |
| Varun Beverages Ltd | ₹476.30 | ₹1,61,080.70 |
| Britannia Industries Ltd | ₹5,569.95 | ₹1,34,162.44 |
| Godrej Consumer Products Ltd | ₹1,203.55 | ₹1,23,124.12 |
Dabur India Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| SBI Contra Fund | 1.81% |
| ICICI Pru Value Discovery Fund | 1.32% |
| Franklin India Focused Equity Fund | 1.31% |
| HDFC Manufacturing Fund | 1.30% |
| HDFC Large Cap Fund | 0.88% |
Dabur India Ltd News
Stock Alert: Dabur India, United Breweries, Coal India, Sonata Software, Titan Company
08 May 2025, 08:05 am
Dabur India AGM scheduled
On 7 August 2025
07 May 2025, 05:22 pm
Board of Dabur India recommends Final Dividend
Of Rs.5.25 per share
07 May 2025, 04:13 pm
Dabur's step-down subsidiary to incorporate new entity in the UK
Dabur India has announced that its step-down wholly owned subsidiary, Dabur International FZE, will incorporate a new entity in the United Kingdom.
16 Apr 2025, 10:24 am
Dabur International FZE plans to incorporate a new entity in UK
15 Apr 2025, 07:09 pm
Dabur India Ltd Stock Analysis
- Annual revenue for Dabur India Ltd increased by 5.25% to ₹9,553.22 crore in FY 2024 from ₹9,076.52 crore in FY 2023.
- Annual Net Profit for Dabur India Ltd increased by 9.90% to ₹1,509.21 crore in FY 2024 from ₹1,373.26 crore in FY 2023.
- Promoter Shareholding in Dabur India Ltd increased by 0.01% in the most recent quarter, from 66.26% in December 2024 to 66.27% in March 2025.
- Dabur India Ltd delivered a 1-year return of -23.66% compared to the Nifty 50, which provided a return of 6.71% as of the last trading session.
- Dabur India Ltd share price moved down by 1.33% from its previous close of INR ₹472.95. The latest Dabur India Ltd share price is INR ₹466.65.
- Dabur India Ltd share price today has been at a low of 464.25 and a high of 470.05. Over the past 52 weeks, the Dabur India Ltd share price has seen a low of 433.30 and a high of 672.
About Dabur India Ltd
Dabur India Ltd is one of India's leading FMCG companies. The company offers ayurvedic and natural healthcare products. It operates in the Fast-Moving Consumer Goods (FMCG) sector, with a strong focus on healthcare, personal care, and food products.
Dabur India was founded by Dr. S. K. Burman in 1884. It has a rich legacy spanning over a century in the Ayurvedic healthcare industry. The company's corporate headquarters or Registered Office is located at 8/3, Asaf Ali Road, New Delhi - 110002.
The Burman family are the promoters of Dabur India. Its promoter shareholding is 66.25% through various family members and investment entities. Since its inception, the promoter family has been actively involved in the company's management and strategic decisions. The vital managerial promoters of the company include:
Dabur India is not the largest FMCG company. However, it is India's largest Ayurvedic medicine manufacturer and the world's largest natural and Ayurvedic products maker. The company leads in several categories, including Chyawanprash, Honey, and Hair Oils.
The company is listed on both the NSE and BSE. Dabur maintains strong corporate governance practices. Also, it has a significant international presence across several countries. The company operates through a vast distribution network over several million retail outlets.
Founding and Legacy Dabur India Ltd was established by Dr. S. K. Burman in 1884. He is a visionary who aimed to provide effective and affordable healthcare solutions based on traditional Indian medicine. Over the years, Dabur has developed from a small pharmacy to a global leader in ayurvedic and natural healthcare products. The company's rich legacy is built on its commitment to quality, innovation, and customer satisfaction.
Promoters and Shareholding The Burman family are the promoters of Dabur India. They hold substantial stakes through various family members and investment entities. The promoter family has been actively involved in the company's management and strategic decisions. Their strong leadership and vision have been instrumental in Dabur's growth and success.
Product Portfolio Dabur's main products include healthcare, haircare, oral care and homecare products. This includes Chyawanprash, honey, and health supplements. The haircare items contain hair oils and shampoos. Oral care products include toothpaste and mouthwash, and home care products involve food and beverages like juices and health drinks. Also, the company offers skin care and beauty products; and ayurvedic medicines. It is not the largest FMCG company. However, Dabur is India's largest Ayurvedic medicine manufacturer. Also, it is the world's largest natural and ayurvedic products maker. The company leads in several categories of products. This includes Chyawanprash, honey, and hair oils.
Market Position and Reach Dabur maintains a significant market presence in India and has a growing international footprint. The company operates through a vast distribution network, reaching millions of retail outlets across India. Millions of consumers trust Dabur's products for their quality and efficacy. The company have strong brand equity and an extensive distribution network. This has helped it maintain its leadership position in the Ayurvedic and natural healthcare segment.
Corporate Governance and Management Dabur maintains strong corporate governance practices. Also, it has a significant international presence across several countries. Dabur India Ltd has a significant international presence, operating in many countries. The company has established a strong foothold in regions such as the Middle East, SAARC nations, Africa, the United States, Europe, and Russia1. Dabur's international business contributes a substantial portion of its revenue. This is driven by its extensive portfolio of over number of herbal and ayurvedic products.
A robust distribution network supports the company's global reach. This ensures that its products are available to consumers worldwide. This international expansion underscores Dabur's commitment to bringing natural and ayurvedic solutions to a global audience. This ensures effective governance and strategic direction.
Dabur India Ltd has a long-standing legacy of excellence in the FMCG sector, particularly in the ayurvedic and natural healthcare industry. It has a strong focus on quality, innovation, and consumer satisfaction. Thus, the company continues to lead the market and maintain its position as a trusted brand in India. Its commitment to sustainability and social responsibility enhances its reputation as a responsible corporate citizen. As Dabur India Ltd continues to grow and evolve, it remains dedicated to improving consumer's lives and contributing to society's overall well-being.
Dabur India was founded by Dr. S. K. Burman in 1884. It has a rich legacy spanning over a century in the Ayurvedic healthcare industry. The company's corporate headquarters or Registered Office is located at 8/3, Asaf Ali Road, New Delhi - 110002.
The Burman family are the promoters of Dabur India. Its promoter shareholding is 66.25% through various family members and investment entities. Since its inception, the promoter family has been actively involved in the company's management and strategic decisions. The vital managerial promoters of the company include:
- Saket Burman (Vice Chairman)
- Mohit Burman (Chairman)
- P D Narang (Whole Time Director)
- Mohit Malhotra (Whole Time Director & CEO)
- P N Vijay (Independent Director)
Dabur India is not the largest FMCG company. However, it is India's largest Ayurvedic medicine manufacturer and the world's largest natural and Ayurvedic products maker. The company leads in several categories, including Chyawanprash, Honey, and Hair Oils.
The company is listed on both the NSE and BSE. Dabur maintains strong corporate governance practices. Also, it has a significant international presence across several countries. The company operates through a vast distribution network over several million retail outlets.
Background Of the Company
Dabur India Ltd is one of India's leading FMCG companies. It is specializing in ayurvedic and natural healthcare products. The company operates in the Fast-Moving Consumer Goods (FMCG) sector. It focuses on healthcare, personal care, and food products. Dabur has a rich legacy spanning over a century in the Ayurvedic healthcare industry.Founding and Legacy Dabur India Ltd was established by Dr. S. K. Burman in 1884. He is a visionary who aimed to provide effective and affordable healthcare solutions based on traditional Indian medicine. Over the years, Dabur has developed from a small pharmacy to a global leader in ayurvedic and natural healthcare products. The company's rich legacy is built on its commitment to quality, innovation, and customer satisfaction.
Promoters and Shareholding The Burman family are the promoters of Dabur India. They hold substantial stakes through various family members and investment entities. The promoter family has been actively involved in the company's management and strategic decisions. Their strong leadership and vision have been instrumental in Dabur's growth and success.
Product Portfolio Dabur's main products include healthcare, haircare, oral care and homecare products. This includes Chyawanprash, honey, and health supplements. The haircare items contain hair oils and shampoos. Oral care products include toothpaste and mouthwash, and home care products involve food and beverages like juices and health drinks. Also, the company offers skin care and beauty products; and ayurvedic medicines. It is not the largest FMCG company. However, Dabur is India's largest Ayurvedic medicine manufacturer. Also, it is the world's largest natural and ayurvedic products maker. The company leads in several categories of products. This includes Chyawanprash, honey, and hair oils.
Market Position and Reach Dabur maintains a significant market presence in India and has a growing international footprint. The company operates through a vast distribution network, reaching millions of retail outlets across India. Millions of consumers trust Dabur's products for their quality and efficacy. The company have strong brand equity and an extensive distribution network. This has helped it maintain its leadership position in the Ayurvedic and natural healthcare segment.
Corporate Governance and Management Dabur maintains strong corporate governance practices. Also, it has a significant international presence across several countries. Dabur India Ltd has a significant international presence, operating in many countries. The company has established a strong foothold in regions such as the Middle East, SAARC nations, Africa, the United States, Europe, and Russia1. Dabur's international business contributes a substantial portion of its revenue. This is driven by its extensive portfolio of over number of herbal and ayurvedic products.
A robust distribution network supports the company's global reach. This ensures that its products are available to consumers worldwide. This international expansion underscores Dabur's commitment to bringing natural and ayurvedic solutions to a global audience. This ensures effective governance and strategic direction.
Dabur India Ltd has a long-standing legacy of excellence in the FMCG sector, particularly in the ayurvedic and natural healthcare industry. It has a strong focus on quality, innovation, and consumer satisfaction. Thus, the company continues to lead the market and maintain its position as a trusted brand in India. Its commitment to sustainability and social responsibility enhances its reputation as a responsible corporate citizen. As Dabur India Ltd continues to grow and evolve, it remains dedicated to improving consumer's lives and contributing to society's overall well-being.
FAQ’s
What is the share price of Dabur India Ltd today?
Dabur India Ltd share price as on 13 Jun 2025 is ₹ 466.65
What is the Market Cap of Dabur India Ltd?
The market cap of Dabur India Ltd stock is ₹83,886.68 Cr.
What is the PE Ratio of Dabur India Ltd?
The Price to Earnings (P/E) Ratio of Dabur India Ltd is 61.40
What is the PB Ratio of Dabur India Ltd?
The Price to Book (P/B) Ratio of Dabur India Ltd is 13.40
What is the 52 week high of Dabur India Ltd Share Price?
The 52 week high of Dabur India Ltd share price stands at ₹672
What is the 52 week low of Dabur India Ltd Share Price?
The 52 week low of Dabur India Ltd share price stands at ₹433.30
How can I buy shares of Dabur India Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Dabur India Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
